Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-468 | Doxorubicin | Chemo | Chemotherapy | 0.0054214 | -0.3392 | 0.9121 | 0.3191 | 2.4137 | 0.0067542 | 0.99424 |
HCC38 | Taxol | Chemo | Chemotherapy | 0.0014659 | -0.3078 | 0.8432 | 0.2758 | 2.3201 | 0.0017274 | 0.99328 |
HCC70 | Cisplatin | Chemo | Chemotherapy | 1.3073 | -0.6832 | 0.2650 | 0.0820 | 1.3165 | 3.0116 | 0.99076 |
MCF7 | Taxol | Chemo | Chemotherapy | 0.0013771 | -0.1059 | 0.7722 | 0.1589 | 1.1560 | 0.0016261 | 0.94939 |
MCF7 | Doxorubicin | Chemo | Chemotherapy | 0.016105 | -0.2856 | 0.6363 | 0.1012 | 0.9326 | 0.024539 | 0.97476 |
CAL-51 | Taxol | Chemo | Chemotherapy | 0.004167 | -0.2200 | 0.6694 | 0.1963 | 1.3689 | 0.0053072 | 0.99639 |
MCF7 | Cisplatin | Chemo | Chemotherapy | 9.3237 | 0.4749 | 0.0631 | 0.0037 | 1.0987 | 15.5357 | 0.99433 |
HCC1143 | Taxol | Chemo | Chemotherapy | 0.0020688 | -0.3349 | 0.8388 | 0.3074 | 2.5955 | 0.0024565 | 0.99279 |
MDA-MB-453 | Cisplatin | Chemo | Chemotherapy | 3.4106 | 0.1328 | 0.0938 | -0.0013 | 3.0256 | 3.151 | 0.9887 |
MDA-MB-361 | Taxol | Chemo | Chemotherapy | 0.0031082 | -0.6090 | 0.9738 | 0.2561 | 2.5508 | 0.0042111 | 0.9201 |
BT-20 | Taxol | Chemo | Chemotherapy | 0.0020158 | -0.5760 | 0.9854 | 0.4456 | 2.0677 | 0.0028795 | 0.99355 |
BT-20 | Doxorubicin | Chemo | Chemotherapy | 0.0087386 | -0.4813 | 0.8279 | 0.3024 | 1.4443 | 0.013048 | 0.9861 |
BT-20 | Cisplatin | Chemo | Chemotherapy | 0.79098 | -0.3367 | 0.3338 | 0.0794 | 0.9579 | 1.7289 | 0.98666 |
HCC1806 | Cisplatin | Chemo | Chemotherapy | 0.82764 | -0.3648 | 0.3231 | 0.1009 | 1.1777 | 1.5296 | 0.98889 |
HCC70 | Doxorubicin | Chemo | Chemotherapy | 0.010621 | -0.7794 | 0.7867 | 0.1459 | 2.0410 | 0.014138 | 0.93856 |
HCC1143 | Doxorubicin | Chemo | Chemotherapy | 0.0092688 | -0.2511 | 0.7180 | 0.1402 | 1.1622 | 0.012302 | 0.98917 |
MDA-MB-453 | Doxorubicin | Chemo | Chemotherapy | 0.0058313 | -0.3476 | 0.7915 | 0.1805 | 1.7510 | 0.0071438 | 0.98132 |
HCC1937 | Taxol | Chemo | Chemotherapy | 0.0024514 | 0.0104 | 0.6576 | 0.2104 | 2.2541 | 0.0024561 | 0.99541 |
HCC38 | Doxorubicin | Chemo | Chemotherapy | 0.0095452 | -0.4061 | 0.7803 | 0.2872 | 1.4810 | 0.01343 | 0.99228 |
BT-549 | Taxol | Chemo | Chemotherapy | 0.0027257 | -0.2074 | 0.6989 | 0.2304 | 1.9420 | 0.0030953 | 0.98743 |
PDX1258 | Taxol | Chemo | Chemotherapy | 0.0021522 | -0.0818 | 0.6797 | 0.2357 | 1.2501 | 0.0022935 | 0.98829 |
PDX1328 | Doxorubicin | Chemo | Chemotherapy | 0.013267 | -0.7789 | 0.8023 | 0.1468 | 1.4934 | 0.021574 | 0.96338 |
HCC1806 | Doxorubicin | Chemo | Chemotherapy | 0.015898 | -0.3241 | 0.6281 | 0.1971 | 1.0948 | 0.021206 | 0.97525 |
CAL-51 | Doxorubicin | Chemo | Chemotherapy | 0.0085841 | -0.4803 | 0.7954 | 0.2347 | 1.0881 | 0.014188 | 0.98761 |
MDA-MB-134-VI | Taxol | Chemo | Chemotherapy | 0.00012515 | -0.7183 | 1.3004 | 0.3511 | 0.5352 | 0.00075273 | 0.89205 |